UB Paderborn / Katalog / Suche / in CDI

Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party

The Journal of hospital infection, 2016-01, Vol.92, p.S1-S44

2016

Volltextzugriff (PDF)

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

Clinical microbiology and infection, 2012-05, Vol.18 (5), p.413-431

2012

Volltextzugriff (PDF)

KS3-1 NDM beta-lactamases; global impact

International journal of antimicrobial agents, 2013-06, Vol.42, p.S8-S8

Livermore, D.M

2013

Volltextzugriff (PDF)

Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria

Clinical microbiology and infection, 2010-07, Vol.16 (7), p.934-944

2010

Volltextzugriff (PDF)

Antibacterial usage in English NHS hospitals as part of a national Antimicrobial Stewardship Programme

Public health (London), 2014-08, Vol.128 (8), p.693-697

2014

Volltextzugriff (PDF)

Multidrug-resistant (MDR) Gram-negative bacteria information leaflets

The Journal of hospital infection, 2016-01, Vol.92 (1), p.86-87

2016

Volltextzugriff (PDF)

Defining an extended-spectrum β-lactamase

Clinical microbiology and infection, 2008-01, Vol.14, p.3-10

Livermore, D.M.

2008

Volltextzugriff (PDF)

The difficulties of identifying and treating Enterobacterales with OXA-48-like carbapenemases

Clinical microbiology and infection, 2020-04, Vol.26 (4), p.401-403

2020

Volltextzugriff (PDF)

The need for new antibiotics

Clinical microbiology and infection, 2004-11, Vol.10 (s4), p.1-9

Livermore, D.M.

2004

Volltextzugriff (PDF)

Trends among pathogens reported as causing bacteraemia in England, 2004–2008

Clinical microbiology and infection, 2011-03, Vol.17 (3), p.451-458

2011

Volltextzugriff (PDF)

Review of health economic models exploring and evaluating treatment and management of hospital-acquired pneumonia and ventilator-associated pneumonia

The Journal of hospital infection, 2020-12, Vol.106 (4), p.745-756

2020

Volltextzugriff (PDF)

P864 Complete nucleotide sequence of pEK499, a multidrug-resistance plasmid from the UK's most prevalent Escherichia coli strain with CTX-M-15 β-lactamase

International journal of antimicrobial agents, 2007, Vol.29, p.S223-S223

2007

Volltextzugriff (PDF)

Antibiotic resistance: location, location, location

Clinical microbiology and infection, 2007-06, Vol.13 (s2), p.7-16

2007

Volltextzugriff (PDF)

Can β-lactams be re-engineered to beat MRSA?

Clinical microbiology and infection, 2006-04, Vol.12 (s2), p.11-16

Livermore, D.M.

2006

Volltextzugriff (PDF)

P1011 Carbapenem resistance in an epidemic CTX-M-15 β-lactamase-producing Escherichia coli strain in the United Kingdom

International journal of antimicrobial agents, 2007, Vol.29, p.S270-S270

2007

Volltextzugriff (PDF)

Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical

Clinical microbiology and infection, 2015-03, Vol.21 (3), p.e25-e27

2015

Volltextzugriff (PDF)

P045 Strain and antibiogram changes, over time, in paediatric cystic fibrosis patients colonised with Pseudomonas aeruginosa

Journal of cystic fibrosis, 2018-06, Vol.17, p.S72-S72

2018

Volltextzugriff (PDF)

Re: “Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis” by Horita et al

Clinical microbiology and infection, 2018-06, Vol.24 (6), p.662-663

2018

Volltextzugriff (PDF)

Orthodox and unorthodox clavulanate combinations against extended-spectrum β-lactamase producers

Clinical microbiology and infection, 2008-01, Vol.14, p.189-193

2008

Volltextzugriff (PDF)

Metallo-β-lactamases among Enterobacteriaceae from routine samples in an Italian tertiary-care hospital and long-term care facilities during 2008

Clinical microbiology and infection, 2011-02, Vol.17 (2), p.181-189

2011

Volltextzugriff (PDF)

P676 Epidemiology of hospital-acquired Klebsiella pneumoniae producing CTX-M β-lactamases in Slovenia

International journal of antimicrobial agents, 2007, Vol.29, p.S161-S162

2007

Volltextzugriff (PDF)

Living with ESBLs

Clinical microbiology and infection, 2008-01, Vol.14, p.1-2

2008

Volltextzugriff (PDF)

Multiresistant acinetobacter in the UK: how big a threat?

The Journal of hospital infection, 2004-11, Vol.58 (3), p.167-169

2004

Volltextzugriff (PDF)

Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid

International journal of antimicrobial agents, 2004-10, Vol.24 (4), p.315-319

2004

Volltextzugriff (PDF)

Development of high-level ceftazidime resistance via single-base substitutions of blaCTX-M-3 in hyper-mutable Escherichia coli

Clinical microbiology and infection, 2006-08, Vol.12 (8), p.803-806

2006

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

KS3-1 NDM beta-lactamases; global impact

Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria

Antibacterial usage in English NHS hospitals as part of a national Antimicrobial Stewardship Programme

Multidrug-resistant (MDR) Gram-negative bacteria information leaflets

Defining an extended-spectrum β-lactamase

The difficulties of identifying and treating Enterobacterales with OXA-48-like carbapenemases

The need for new antibiotics

Trends among pathogens reported as causing bacteraemia in England, 2004–2008

Review of health economic models exploring and evaluating treatment and management of hospital-acquired pneumonia and ventilator-associated pneumonia

P864 Complete nucleotide sequence of pEK499, a multidrug-resistance plasmid from the UK's most prevalent Escherichia coli strain with CTX-M-15 β-lactamase

Antibiotic resistance: location, location, location

Can β-lactams be re-engineered to beat MRSA?

P1011 Carbapenem resistance in an epidemic CTX-M-15 β-lactamase-producing Escherichia coli strain in the United Kingdom

Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical

P045 Strain and antibiogram changes, over time, in paediatric cystic fibrosis patients colonised with Pseudomonas aeruginosa

Re: “Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis” by Horita et al

Orthodox and unorthodox clavulanate combinations against extended-spectrum β-lactamase producers

Metallo-β-lactamases among Enterobacteriaceae from routine samples in an Italian tertiary-care hospital and long-term care facilities during 2008

P676 Epidemiology of hospital-acquired Klebsiella pneumoniae producing CTX-M β-lactamases in Slovenia

Living with ESBLs

Multiresistant acinetobacter in the UK: how big a threat?

Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid

Development of high-level ceftazidime resistance via single-base substitutions of blaCTX-M-3 in hyper-mutable Escherichia coli

Suchergebnisse filtern